CHDD
CHDD popup menu
 
chdd logo
Center on Human Development and Disability
About CHDD | IDDRC | UCEDD   

CHDD is located on the Lake Washington Ship Canal

Home Page

Collaborative
Research Areas


Research Affiliates

Core Services

Animal
Behavior
Core


Brain
Imaging
Core


Clinical
Translational
Core


Genetics
Core

Nina Isoherranen, Ph.D.

Associate Professor of Pharmaceutics
Research Affiliate, Center on Human Development and Disability
ni2@uw.edu
206-543-2517
University of Washington
Box 357610
Seattle, WA 98195-7610

Nina Isoherranen

Dr. Isoherranen’s research focuses on changes in drug metabolism during pregnancy and mechanisms by which drug disposition changes during pregnancy. Her laboratory has developed special expertise in modeling and simulation of maternal-fetal disposition of xenobiotics across the gestational timeline and in evaluating the magnitude of changes in drug disposition during pregnancy. There is now considerable evidence that the expression and activity of various metabolic enzymes and transporters are significantly altered during pregnancy. This may lead to decreased exposures to therapeutic compounds during pregnancy leading to therapeutic failure of treatments such as anti-infectives, antiepileptics, and drugs used to treat gestational hypertension, diabetes, depression, and addiction. Such therapeutic failures put the developing baby at risk for developmental disabilities and other adverse effects. In addition, altered metabolism during pregnancy may increase the maternal and fetal exposure to harmful metabolites that have direct toxic effects to the fetus.

Dr. Isoherranen’s lab web page


University of Washington • Center on Human Development and Disability • Box 357920 • Seattle WA 98195-7920 USA • 206-543-7701 • chdd@uw.edu